PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
1-Year Return
55.52%
This Quarter Return
-0.56%
1 Year Return
+55.52%
3 Year Return
+234.94%
5 Year Return
–
10 Year Return
–
AUM
$15.7M
AUM Growth
-$1.33M
(-7.8%)
Cap. Flow
-$983K
Cap. Flow
% of AUM
-6.27%
Top 10 Holdings %
Top 10 Hldgs %
39.89%
Holding
471
New
38
Increased
139
Reduced
174
Closed
55
Top Buys
| 1 |
DexCom
DXCM
|
$67.2K |
| 2 |
Penumbra
PEN
|
$64.7K |
| 3 |
Meta Platforms (Facebook)
META
|
$55.7K |
| 4 |
Becton Dickinson
BDX
|
$55.2K |
| 5 |
GitLab
GTLB
|
$51.5K |
Top Sells
| 1 |
Ferguson
FERG
|
$877K |
| 2 |
Adobe
ADBE
|
$85.2K |
| 3 |
Steris
STE
|
$78.2K |
| 4 |
Neurocrine Biosciences
NBIX
|
$64.8K |
| 5 |
CVS Health
CVS
|
$62.9K |
Sector Composition
| 1 | Technology | 30.09% |
| 2 | Industrials | 22.23% |
| 3 | Healthcare | 19.2% |
| 4 | Financials | 15.68% |
| 5 | Communication Services | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Edwards Lifesciences
EW
$47.5B
| $8.06K | 0.05% |
97,568
+2,954
| +3% | +$244 |
|
202
Citizens Financial Group
CFG
$22.3B
| $8.01K | 0.05% |
233,161
-35,317
| -13% | -$1.21K |
|
203
Charles Schwab
SCHW
$167B
| $7.98K | 0.05% |
+111,086
| New | +$7.98K |
|
204
PayPal
PYPL
$65.2B
| $7.48K | 0.05% |
86,941
+19,648
| +29% | +$1.69K |
|
205
Envista
NVST
$3.54B
| $7.44K | 0.05% |
226,888
-1,428,768
| -86% | -$46.9K |
|
206
Confluent
CFLT
$6.67B
| $7.38K | 0.05% |
+310,569
| New | +$7.38K |
|
207
Cerus
CERS
$255M
| $7.32K | 0.05% |
2,033,336
+162,346
| +9% | +$584 |
|
208
Morgan Stanley
MS
$236B
| $6.77K | 0.04% |
85,626
-23,316
| -21% | -$1.84K |
|
209
Cognex
CGNX
$7.55B
| $6.48K | 0.04% |
156,402
+93,229
| +148% | +$3.86K |
|
210
Enterprise Financial Services Corp
EFSC
$2.24B
| $6.41K | 0.04% |
145,628
-29,513
| -17% | -$1.3K |
|
211
S&P Global
SPGI
$164B
| $6.37K | 0.04% |
20,846
+3,648
| +21% | +$1.11K |
|
|
FRC
212
DELISTED
First Republic Bank
FRC
| $6.3K | 0.04% |
48,283
-324
| -0.7% | -$42 |
|
|
LTHM
213
DELISTED
Livent Corporation
LTHM
| $6.12K | 0.04% |
199,511
+65,034
| +48% | +$1.99K |
|
214
Albemarle
ALB
$9.6B
| $6.05K | 0.04% |
22,888
-3,227
| -12% | -$853 |
|
215
Comerica
CMA
$8.85B
| $6.05K | 0.04% |
+85,046
| New | +$6.05K |
|
|
INFI
216
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $5.95K | 0.04% |
5,000,000
| – | – |
|
217
Zai Lab
ZLAB
$3.42B
| $5.87K | 0.04% |
171,651
+27,654
| +19% | +$946 |
|
218
Amgen
AMGN
$153B
| $5.74K | 0.04% |
25,461
-3,256
| -11% | -$734 |
|
219
Deere & Co
DE
$128B
| $5.4K | 0.03% |
16,186
+1,230
| +8% | +$411 |
|
220
Cullen/Frost Bankers
CFR
$8.24B
| $5.27K | 0.03% |
+39,883
| New | +$5.27K |
|
221
Sabre
SABR
$675M
| $5.26K | 0.03% |
1,021,602
+24,113
| +2% | +$124 |
|
222
Medtronic
MDT
$119B
| $5.22K | 0.03% |
64,626
+7,681
| +13% | +$620 |
|
223
Chemed
CHE
$6.79B
| $5.11K | 0.03% |
11,706
-1,067
| -8% | -$466 |
|
224
Biomea Fusion
BMEA
$114M
| $4.89K | 0.03% |
500,000
+466,845
| +1,408% | +$4.57K |
|
225
Veeva Systems
VEEV
$44.7B
| $4.87K | 0.03% |
29,518
+17,904
| +154% | +$2.95K |
|